Published Date: 02 Mar 2023
Even partial vaccinations have been associated with fewer people becoming infected with COVID-19 in observational studies, although more research is needed on the spread of new and emerging diseases.
Read Full NewsBreast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the main causes of cancer-related mortality. Precisely predicting whether ...
The periodization of exercise training could give people undergoing cancer treatment and those in recovery a tailored pathway to support strength and resilience during the challenging journey of cancer care and rehabilitation.
A new clinical trial led by University of Alberta researchers is exploring whether heavy strength training is a safe and beneficial way to help combat the long-term physical challenges faced by head and neck cancer survivors.
1.
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer
2.
GLP-1 receptor agonists, cancer risk and questionable significance
3.
Experts suggest Michelangelo depicted breast cancer in the Sistine Chapel fresco
4.
A study on lung cancer provides additional proof of the value of screening.
5.
Metastatic breast cancer can be effectively treated with cyclical estrogen and anti-estrogen therapy.
1.
Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients
2.
Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells
3.
Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology
4.
All You Need To Know About Partial Thromboplastin Time (PTT) Test
5.
Understanding Odontogenic Keratocyst: Symptoms, Causes, and Treatments from Dental Experts
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation